Jung-Kwoun Kim

Title: Innovations of Jung-Kwoun Kim: Pioneering Sustained-Release Microcapsules

Introduction

Jung-Kwoun Kim, an inventive spirit hailing from Gyeongsangnam-do, South Korea, has made strides in the field of pharmaceutical innovation. With one notable patent to his name, he has contributed significantly to enhanced drug delivery systems, showcasing his expertise in the realm of microencapsulation.

Latest Patents

Jung-Kwoun Kim holds a patent for the "Preparation method of sustained-release microcapsules having initial burst inhibiting property and the microcapsules thereby." This inventive method focuses on a longer sustained-release formulation that incorporates bioactive substances. More specifically, this innovation involves an intricate process where an emulsion containing these bioactive substances, along with a biocompatible polymer and polyvinylpyrrolidone, is combined with an aqueous solution. This technology promises to improve the efficacy of drugs by controlling their release rates.

Career Highlights

Kim is currently associated with Dongkook Pharmaceutical Co., Ltd., where he leverages his innovative prowess to advance pharmaceutical formulations. His work stands out not only for its technical merit but also for its potential impact on patient treatment protocols. The development of microcapsules with sustained release properties presents considerable advantages in achieving therapeutic goals.

Collaborations

Throughout his career, Jung-Kwoun Kim has collaborated with notable colleagues, including Nak-Hyun Lim and Hyung-Joon Jung. These partnerships reflect a commitment to collaborative innovation, driving forward the boundaries of pharmaceutical research and development. Their collective expertise contributes significantly to the advancements made within their field.

Conclusion

Jung-Kwoun Kim exemplifies the innovative spirit necessary for transforming pharmaceutical practices. His dedication to developing sophisticated drug delivery systems positions him as a key player in the industry. With ongoing advancements and collaborations, Kim's contributions will likely continue to enhance therapeutic outcomes for patients worldwide.